NCT06837844 Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty
| NCT ID | NCT06837844 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kafrelsheikh University |
| Condition | Intrathecal Dexmedetomidine |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2025-02-20 |
| Primary Completion | 2025-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2025-02-20 with a primary completion date of 2025-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this work is to evaluate the effect of combined intrathecal dexmedetomidine and adductor canal block for analgesia after total knee arthroplasty (TKA).
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 75 years. * Both sexes. * American Society of Anesthesiology (ASA) physical status I-II. * Scheduled for total knee arthroplasty under spinal anesthesia. Exclusion Criteria: * Patients with neurological or intellectual disability. * History of allergy to local anesthetics or dexmedetomidine . * Infection at the injection site. * Prolonged use of analgesic or sedative medications. * Coagulation abnormalities. * Pregnancy. * Obesity \[body mass index (BMI) \> 30 kg/m2\].
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06837844 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Intrathecal Dexmedetomidine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06837844 currently recruiting?
Yes, NCT06837844 is actively recruiting participants. Contact the research team at Sherifhafez1980@gmail.com for enrollment information.
Where is the NCT06837844 trial being conducted?
This trial is being conducted at Kafr ash Shaykh, Egypt.
Who is sponsoring the NCT06837844 clinical trial?
NCT06837844 is sponsored by Kafrelsheikh University. The trial plans to enroll 75 participants.